IN2014MN02060A - - Google Patents
Info
- Publication number
- IN2014MN02060A IN2014MN02060A IN2060MUN2014A IN2014MN02060A IN 2014MN02060 A IN2014MN02060 A IN 2014MN02060A IN 2060MUN2014 A IN2060MUN2014 A IN 2060MUN2014A IN 2014MN02060 A IN2014MN02060 A IN 2014MN02060A
- Authority
- IN
- India
- Prior art keywords
- amino acid
- amount
- clinical condition
- biological material
- index value
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 abstract 7
- 201000010099 disease Diseases 0.000 abstract 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 7
- 239000012620 biological material Substances 0.000 abstract 4
- 238000003745 diagnosis Methods 0.000 abstract 3
- 238000004458 analytical method Methods 0.000 abstract 2
- 238000005259 measurement Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000002596 correlated effect Effects 0.000 abstract 1
- 238000012284 sample analysis method Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6806—Determination of free amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/89—Inverse chromatography
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
- G01N2030/8818—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8877—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Evolutionary Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Epidemiology (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Primary Health Care (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012061305 | 2012-03-18 | ||
| PCT/JP2013/001849 WO2013140785A1 (ja) | 2012-03-18 | 2013-03-18 | 疾患サンプル分析装置、分析システム及び分析方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN02060A true IN2014MN02060A (Direct) | 2015-08-21 |
Family
ID=49222264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2060MUN2014 IN2014MN02060A (Direct) | 2012-03-18 | 2013-03-18 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20150079623A1 (Direct) |
| EP (3) | EP2829877B1 (Direct) |
| JP (3) | JP6037388B2 (Direct) |
| CN (11) | CN110133300B (Direct) |
| IN (1) | IN2014MN02060A (Direct) |
| TW (2) | TWI664425B (Direct) |
| WO (1) | WO2013140785A1 (Direct) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015087985A1 (ja) | 2013-12-11 | 2015-06-18 | 株式会社資生堂 | 腎不全の早期診断マーカー |
| HK1251299A1 (en) * | 2015-06-10 | 2019-01-25 | Kanazawa University | Disease-state biomarker for renal disease |
| CN108587991B (zh) * | 2015-10-10 | 2021-03-05 | 中国科学院南海海洋研究所 | 一种高产环肽类化合物的菌株 |
| JP7123329B2 (ja) * | 2016-05-17 | 2022-08-23 | 国立大学法人大阪大学 | 腎臓病の予後予測方法及びシステム |
| SG11201810254UA (en) * | 2016-05-17 | 2018-12-28 | Univ Osaka | Blood sample analysis method and system, for determining diabetes |
| AU2017361186A1 (en) | 2016-11-15 | 2019-06-13 | Shiseido Company, Ltd. | Multidimensional chromatographic analysis method and analysis system |
| JPWO2018159833A1 (ja) * | 2017-03-02 | 2020-01-16 | 株式会社ニコン | 細胞の判別方法、がんの検査方法、計測装置、がんの検査装置および検査プログラム |
| SG11201908102TA (en) | 2017-03-03 | 2019-10-30 | Shiseido Co Ltd | Novel compound, fluorescence derivatization reagent including said novel compound, method for optically resolving optical isomer of amino acid in which said novel compound is used, and fluorescence derivatized amino acid |
| JP7364166B2 (ja) * | 2018-06-07 | 2023-10-18 | 国立大学法人金沢大学 | 腎障害の予防又は治療用の医薬組成物 |
| WO2020045364A1 (ja) * | 2018-08-27 | 2020-03-05 | 株式会社 資生堂 | 乾癬を判定するための皮膚試料の分析方法及びシステム |
| TW202028747A (zh) | 2018-10-17 | 2020-08-01 | 日商資生堂股份有限公司 | 絲球體過濾能力之決定方法 |
| WO2020196437A1 (ja) * | 2019-03-22 | 2020-10-01 | Kagami株式会社 | 腎病態の評価を補助する方法、腎病態の評価システム及び腎病態の評価プログラム |
| EP3943948B1 (en) | 2019-03-22 | 2025-07-09 | Kagami Inc. | Method for assisting evaluation of condition of kidneys, system for evaluating condition of kidneys, and program for evaluating condition of kidneys |
| JP7434678B2 (ja) * | 2019-05-20 | 2024-02-21 | 花王株式会社 | 認知症又はそのリスクの検査方法 |
| US20230037869A1 (en) | 2019-12-27 | 2023-02-09 | Kagami Inc. | Method and system for estimating renal function |
| CN121324516A (zh) * | 2020-09-16 | 2026-01-13 | 上海市皮肤病医院 | 基于代谢组学的泛发性脓疱型银屑病诊断标志物及其应用 |
| CN111899883B (zh) * | 2020-09-29 | 2020-12-15 | 平安科技（深圳）有限公司 | 少样本或零样本的疾病预测设备、方法、装置及存储介质 |
| JP7600016B2 (ja) * | 2021-03-30 | 2024-12-16 | 花王株式会社 | 高次脳機能の測定方法 |
| JPWO2023033178A1 (Direct) * | 2021-09-03 | 2023-03-09 |
Family Cites Families (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4290893A (en) * | 1979-05-08 | 1981-09-22 | Yeda Research & Development Co. Ltd. | Separation of amino acids by liquid chromatography using chiral eluants |
| NZ236114A (en) * | 1989-11-22 | 1993-04-28 | Merrell Dow Pharma | Peptide antagonists of bombesin and of gastrin releasing peptide, and pharmaceutical compositions |
| US5374651A (en) * | 1991-09-27 | 1994-12-20 | Board Of Regents, The University Of Texas System | Methods and compositions for the treatment of hypotension with arginine free essential and essential amino acids and arginine derivatives |
| WO1996028470A2 (en) * | 1995-03-09 | 1996-09-19 | Neurocrine Biosciences, Inc. | Peptide analogues of human myelin basic protein useful in treating multiple sclerosis |
| JPH0975078A (ja) * | 1995-09-13 | 1997-03-25 | Ikeda Shokken Kk | 耐熱性ｄ−アミノ酸オキシダーゼ、その製造法および微生物 |
| US5780435A (en) * | 1995-12-15 | 1998-07-14 | Praecis Pharmaceuticals Incorporated | Methods for treating prostate cancer with LHRH-R antagonists |
| EP0882736A1 (en) * | 1997-06-02 | 1998-12-09 | Laboratoire Theramex S.A. | LH-RH peptide analogues, their uses and pharmaceutical compositions containing them |
| EP1085885B1 (en) * | 1998-06-11 | 2003-10-01 | Fox Chase Cancer Center | Method for assessing a diabetic's risk of experiencing a diabetes-associated pathologic condition |
| JP4949560B2 (ja) * | 1999-05-14 | 2012-06-13 | ブランディーズ・ユニバーシティ | 核酸をベースとする検出 |
| US6479063B2 (en) * | 1999-12-27 | 2002-11-12 | Kenneth Weisman | Therapeutic uses of hormonal manipulation using combinations of various agents to treat atherosclerosis |
| US7223558B2 (en) * | 2001-07-11 | 2007-05-29 | Bristol-Myers Squibb Company | Polynucleotides encoding three novel human cell surface proteins with leucine rich repeats and immunologobulin folds, BGS2, 3, and 4 and variants thereof |
| FR2828693B1 (fr) * | 2001-08-14 | 2004-06-18 | Exonhit Therapeutics Sa | Nouvelle cible moleculaire de la neurotoxicite |
| EP1485116A4 (en) * | 2002-02-27 | 2006-06-07 | Univ Wake Forest | ANGIOTENSIN- (1-7) AND AGONISTS OF ANGIOTENSIN- (1-7) FOR THE INHIBITION OF GROWTH OF CANCER CELLS |
| FR2838444B1 (fr) * | 2002-04-10 | 2016-01-01 | Neovacs | Nouveaux peptides et leur application en therapeutique |
| US20070298041A1 (en) * | 2002-06-28 | 2007-12-27 | Tomlinson Ian M | Ligands That Enhance Endogenous Compounds |
| AU2003244205A1 (en) * | 2002-07-04 | 2004-01-23 | Mitsubishi Pharma Corporation | Method of examining and diagnosing integration dysfunction syndrome |
| GB0219776D0 (en) * | 2002-08-24 | 2002-10-02 | Oxford Glycosciences Uk Ltd | A protein involved in carcinoma |
| GB0223424D0 (en) * | 2002-10-09 | 2002-11-13 | Imp College Innovations Ltd | Disease-associated gene |
| AU2003289263A1 (en) * | 2002-12-09 | 2004-06-30 | Ajinomoto Co., Inc. | Organism condition information processor, organism condition information processing method, organism condition information managing system, program, and recording medium |
| WO2004063221A1 (ja) * | 2002-12-26 | 2004-07-29 | Takeda Pharmaceutical Company Limited | メタスチン誘導体およびその用途 |
| AU2003900777A0 (en) * | 2003-02-21 | 2003-03-13 | Medvet Science Pty. Ltd. | A method of diagnosis and treatment |
| CA2518703A1 (en) * | 2003-03-10 | 2004-09-23 | Sionex Corporation | Systems for differential ion mobility analysis |
| US20060217316A1 (en) * | 2003-04-02 | 2006-09-28 | Ragab El-Rashidy | Method for the treatment of prostate cancer |
| JP4291628B2 (ja) | 2003-06-12 | 2009-07-08 | 株式会社資生堂 | 液体クロマトグラフ装置及び試料に含まれる光学異性体の分析方法 |
| CN1557823A (zh) * | 2004-02-12 | 2004-12-29 | 窦德献 | L-或d-氨基酸合铂配位体、制备方法及其用途 |
| DE602005025211D1 (de) * | 2004-04-09 | 2011-01-20 | Us Gov Health & Human Serv | Diagnosegerät zur diagnose gutartiger gegenüber bösartigen schilddrüsenläsionen |
| AT500483B1 (de) * | 2004-07-13 | 2006-01-15 | Mattner Frank Dr | Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung |
| GB0417887D0 (en) * | 2004-08-11 | 2004-09-15 | Ares Trading Sa | Protein |
| CN101142483A (zh) * | 2005-03-18 | 2008-03-12 | 株式会社资生堂 | 以鳞状上皮细胞癌抗原为指标的皮肤性状的评价方法 |
| CN101189243A (zh) * | 2005-04-06 | 2008-05-28 | 阿斯利康(瑞典)有限公司 | 取代的杂环及其作为chk1、pdk1和pak抑制剂的应用 |
| JP2007077104A (ja) * | 2005-09-16 | 2007-03-29 | Shiseido Co Ltd | 血管内皮増殖因子阻害剤 |
| BRPI0708485A2 (pt) * | 2006-03-02 | 2011-05-31 | Perkinelmer Las Inc | métodos para distinguir isÈmeros usando espectrometria de massa |
| US20070258899A1 (en) * | 2006-03-31 | 2007-11-08 | Karyon-Ctt Ltd | Diagnostic and therapeutic agents |
| JP5005955B2 (ja) * | 2006-05-24 | 2012-08-22 | 田辺三菱製薬株式会社 | 被験物質の脂質代謝異常症誘発可能性を予測する方法 |
| ATE537450T1 (de) * | 2006-06-30 | 2011-12-15 | Schering Corp | Igfbp2-biomarker |
| CN101578287B (zh) * | 2006-09-06 | 2012-09-05 | 阿特纳赞塔里斯有限公司 | 地索拉唑及其衍生物与细胞结合分子的轭合物，新的地索拉唑衍生物，其制备方法及其应用 |
| EP1900742A1 (en) * | 2006-09-07 | 2008-03-19 | AEterna Zentaris GmbH | Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof |
| US20090075284A1 (en) * | 2006-09-19 | 2009-03-19 | The Regents Of The University Of Michigan | Metabolomic profiling of prostate cancer |
| AU2008206039A1 (en) * | 2007-01-18 | 2008-07-24 | Sepracor Inc. | Inhibitors of D-amino acid oxidase |
| EP2129775A1 (en) * | 2007-02-12 | 2009-12-09 | Anthrogenesis Corporation | Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations |
| US8034780B2 (en) * | 2007-07-16 | 2011-10-11 | Mcphail Kerry Leigh | Isolation, purification, and structure elucidation of the antiproliferative compound coibamide A |
| JPWO2009091023A1 (ja) * | 2008-01-17 | 2011-05-26 | 東レ株式会社 | 腎癌の診断又は検出のための組成物及び方法 |
| JP2009184981A (ja) * | 2008-02-07 | 2009-08-20 | Shiseido Co Ltd | 抗ｄ−アミノ酸モノクローナル抗体及び、抗ｄ−アミノ酸モノクローナル抗体を用いたｄ−アミノ酸の免疫学的分析方法 |
| AR071774A1 (es) * | 2008-05-14 | 2010-07-14 | Takeda Pharmaceutical | Sal de acetato de un compuesto peptidico que tiene actividad antitumoral y su uso. |
| WO2009143489A2 (en) * | 2008-05-22 | 2009-11-26 | Archer Pharmaceuticals, Inc. | Modulation of angiogenesis by a-beta peptide fragments |
| US20110311650A1 (en) * | 2008-07-07 | 2011-12-22 | Thomas Wang | Multiplexed biomarkers of insulin resistance |
| JP2010038796A (ja) * | 2008-08-06 | 2010-02-18 | Human Metabolome Technologies Inc | 疾患マーカー、および、疾患マーカーの測定方法 |
| US8592642B2 (en) * | 2008-08-26 | 2013-11-26 | Kyushu University, National University Corporation | Evaluation/screening method for diseases associated with D-amino acid utilizing DAO1-/-mouse |
| US8722343B2 (en) * | 2008-11-21 | 2014-05-13 | Carla Perego | Methods and compositions for the diagnosis and treatment of diabetes |
| ES2799327T3 (es) * | 2009-05-05 | 2020-12-16 | Infandx Ag | Método para diagnosticar asfixia |
| CN101619092B (zh) * | 2009-08-06 | 2012-08-15 | 中国人民解放军第三军医大学第二附属医院 | 肿瘤抗原trag-3模拟表位肽及其应用 |
| US20110064828A1 (en) * | 2009-09-11 | 2011-03-17 | Novelos Therapeutics, Incorporated | Treatment of metastatic tumors and other conditions |
| JP2011247869A (ja) * | 2010-04-27 | 2011-12-08 | Kobe Univ | メタボローム解析手法を用いた特定疾患の検査方法 |
| CN102079771B (zh) * | 2010-12-10 | 2012-10-03 | 郑州大学 | 具有抗肿瘤活性的雌甾氨基酸酯化合物及其合成方法 |
-
2013
- 2013-03-18 IN IN2060MUN2014 patent/IN2014MN02060A/en unknown
- 2013-03-18 EP EP13764636.0A patent/EP2829877B1/en active Active
- 2013-03-18 CN CN201910586450.6A patent/CN110133300B/zh not_active Expired - Fee Related
- 2013-03-18 CN CN201910591882.6A patent/CN110161256B/zh active Active
- 2013-03-18 WO PCT/JP2013/001849 patent/WO2013140785A1/ja not_active Ceased
- 2013-03-18 EP EP20152640.7A patent/EP3663758A1/en not_active Withdrawn
- 2013-03-18 CN CN201910586159.9A patent/CN110133299A/zh active Pending
- 2013-03-18 JP JP2013055673A patent/JP6037388B2/ja active Active
- 2013-03-18 CN CN201910591893.4A patent/CN110133301B/zh active Active
- 2013-03-18 TW TW106126498A patent/TWI664425B/zh not_active IP Right Cessation
- 2013-03-18 EP EP20207502.4A patent/EP3795997B1/en active Active
- 2013-03-18 US US14/385,871 patent/US20150079623A1/en not_active Abandoned
- 2013-03-18 TW TW102109586A patent/TWI615614B/zh not_active IP Right Cessation
- 2013-03-18 CN CN201380019921.6A patent/CN104246497B/zh not_active Expired - Fee Related
- 2013-03-18 CN CN201910585495.1A patent/CN110133295A/zh active Pending
- 2013-03-18 CN CN201910585588.4A patent/CN110133297A/zh active Pending
- 2013-03-18 CN CN201910585530.XA patent/CN110133296B/zh active Active
- 2013-03-18 CN CN201710913596.8A patent/CN107449923B/zh not_active Expired - Fee Related
- 2013-03-18 CN CN201910585649.7A patent/CN110133298A/zh active Pending
- 2013-03-18 CN CN202210524153.0A patent/CN114966050A/zh active Pending
-
2016
- 2016-10-26 JP JP2016209988A patent/JP6214016B2/ja active Active
-
2017
- 2017-09-13 JP JP2017175949A patent/JP6391787B2/ja active Active
-
2018
- 2018-09-21 US US16/137,968 patent/US20190025320A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN02060A (Direct) | ||
| EP2573192A4 (en) | METHOD AND KIT FOR DIAGNOSING DISEASE ASSOCIATED WITH AIM | |
| BR112015003715A8 (pt) | análise de raman, de infravermelho, ou de raman-infravermelho da estrutura de proteína de plasma de sangue periférico e sua relação para desenvolvimento cognitivo no mal de alzheimer | |
| BR112013010015A2 (pt) | aparelho e método para detecção não invasiva de doenças que afetam as propriedades estruturais em tecidos biológicos | |
| GB2488700B (en) | Methods for monitoring disease conditions by analysis of the full repertoire of CDR3 sequences of an individual | |
| MX2015005276A (es) | Sistema y metodos para diagnostico de la salud. | |
| WO2013040099A3 (en) | Sepsis prognosis biomarkers | |
| IN2014DN10121A (Direct) | ||
| HK1215259A1 (zh) | 檢測抗苗勒管激素的同種型的抗體組合物及免疫測定方法 | |
| WO2013190075A3 (en) | Specific biomarkers for hepatocellular carcinoma (hcc) | |
| JP2012529655A5 (Direct) | ||
| MX342146B (es) | Sistema de monitoreo para monitorear un paciente y detectar delirio del paciente. | |
| EP2569635A4 (en) | METHOD FOR DIAGNOSIS AND / OR TREATMENT OF ENZEPHALITIS OR EPILEPSY | |
| SG10201408392PA (en) | Methods of determining patient response by measurement of her-3 | |
| WO2012078623A3 (en) | Biomarkers for monitoring treatment of neuropsychiatric diseases | |
| EP2579043A4 (en) | DETECTION METHOD | |
| TN2015000161A1 (en) | Methylglyoxal as a marker of cancer | |
| WO2009001545A1 (ja) | 移植片対宿主疾患の検査および治療方法 | |
| WO2010099137A3 (en) | In situ methods for monitoring the emt status of tumor cells in vivo | |
| HK1207684A1 (en) | Mitochondrial toxicity test | |
| GB2515713A (en) | Methods, packaging and apparatus for collection of biological samples | |
| JP2007289224A5 (Direct) | ||
| WO2012109258A3 (en) | Compositions adn methods for monitoring oxalate | |
| SI1990420T1 (sl) | Postopek za detekcijo in vivo aktivnosti nevrotripsina, uporaba metode in uporaba c-terminalnega 22-kda fragmenta agrina kot biomarkerja pri diagnozi in monitoringu motenj povezanih z nevrotripsinom | |
| WO2012167887A8 (en) | Diagnostic use of prosomatostatin |